According to Latest Study, the global market for Pharmaceutical Excipient Albumin should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Pharmaceutical Excipient Albumin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Pharmaceutical Excipient Albumin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Human Serum Albumin segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Cell Culture Media has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Pharmaceutical Excipient Albumin include CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion and LFB Group, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries
This report aims to provide a comprehensive study of the global market for Pharmaceutical Excipient Albumin. Report Highlights:
(1) Global Pharmaceutical Excipient Albumin market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Pharmaceutical Excipient Albumin market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Pharmaceutical Excipient Albumin market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Pharmaceutical Excipient Albumin segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Pharmaceutical Excipient Albumin segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Pharmaceutical Excipient Albumin, capacity, production and trends.
(7) Pharmaceutical Excipient Albumin industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Human Serum Albumin
Recombinant Albumin
Market segment by application, can be divided into
Cell Culture Media
Medical Supplements
Market segment by players, this report covers
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
1 Market Overview
1.1 Pharmaceutical Excipient Albumin Definition
1.2 Global Pharmaceutical Excipient Albumin Market Size and Forecast
1.2.1 By Revenue, Global Pharmaceutical Excipient Albumin Market Size, 2018-2029
1.2.2 By Sales Volume, Global Pharmaceutical Excipient Albumin Market Size, 2018-2029
1.2.3 Global Pharmaceutical Excipient Albumin Price Trend, 2018-2029
1.3 China Pharmaceutical Excipient Albumin Market Size and Forecast
1.3.1 By Revenue, China Pharmaceutical Excipient Albumin Market Size, 2018-2029
1.3.2 By Sales Volume, China Pharmaceutical Excipient Albumin Market Size, 2018-2029
1.3.3 China Pharmaceutical Excipient Albumin Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Pharmaceutical Excipient Albumin Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Pharmaceutical Excipient Albumin Share in Global Market, 2018-2029
1.4.3 Pharmaceutical Excipient Albumin Market Size: China VS Global, 2018-2029
1.5 Pharmaceutical Excipient Albumin Market Dynamics
1.5.1 Pharmaceutical Excipient Albumin Market Drivers
1.5.2 Pharmaceutical Excipient Albumin Market Restraints
1.5.3 Pharmaceutical Excipient Albumin Industry Trends
1.5.4 Pharmaceutical Excipient Albumin Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Pharmaceutical Excipient Albumin Revenue by Company, 2018-2023
2.2 Global Pharmaceutical Excipient Albumin Sales Volume by Company, 2018-2023
2.3 Global Pharmaceutical Excipient Albumin Price by Company, 2018-2023
2.4 Global Pharmaceutical Excipient Albumin Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Pharmaceutical Excipient Albumin Concentration Ratio
2.6 Global Pharmaceutical Excipient Albumin Mergers & Acquisitions, Expansion Plans
2.7 Global Pharmaceutical Excipient Albumin Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Pharmaceutical Excipient Albumin Revenue by Company, 2018-2023
3.2 China Pharmaceutical Excipient Albumin Sales Volume by Company, 2018-2023
3.3 China Pharmaceutical Excipient Albumin Pharmaceutical Excipient Albumin Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Pharmaceutical Excipient Albumin Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Pharmaceutical Excipient Albumin Domestic VS Export
3.6 China Market, Pharmaceutical Excipient Albumin Import & Export
3.6.1 China Market, Pharmaceutical Excipient Albumin Import & Export, 2018-2029
3.6.2 China Pharmaceutical Excipient Albumin Import & Export Trends
3.6.3 Main Sources of China Pharmaceutical Excipient Albumin Import
3.6.4 Export Destination of China Pharmaceutical Excipient Albumin
4 Pharmaceutical Excipient Albumin Production by Region
4.1 Global Pharmaceutical Excipient Albumin Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Pharmaceutical Excipient Albumin Manufacturers
4.3 Global Major Manufacturers, Pharmaceutical Excipient Albumin Capacity Expansion and Future Plans
4.4 Global Pharmaceutical Excipient Albumin Capacity by Region
4.5 Global Pharmaceutical Excipient Albumin Production by Region
4.5.1 Global Pharmaceutical Excipient Albumin Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Pharmaceutical Excipient Albumin Production by Region, 2018-2023
4.5.3 Global Pharmaceutical Excipient Albumin Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Pharmaceutical Excipient Albumin Industry Chain
5.2 Pharmaceutical Excipient Albumin Upstream Analysis
5.2.1 Pharmaceutical Excipient Albumin Core Raw Materials
5.2.2 Main Manufacturers of Pharmaceutical Excipient Albumin Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Pharmaceutical Excipient Albumin Production Mode
5.6 Pharmaceutical Excipient Albumin Procurement Model
5.7 Pharmaceutical Excipient Albumin Industry Sales Model and Sales Channels
5.7.1 Pharmaceutical Excipient Albumin Sales Model
5.7.2 Pharmaceutical Excipient Albumin Typical Distributors
6 Sights by Type
6.1 Pharmaceutical Excipient Albumin Classification
6.1.1 Human Serum Albumin
6.1.2 Recombinant Albumin
6.2 By Type, Global Pharmaceutical Excipient Albumin Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Pharmaceutical Excipient Albumin Revenue, 2018-2029
6.4 By Type, Global Pharmaceutical Excipient Albumin Sales Volume, 2018-2029
6.5 By Type, Global Pharmaceutical Excipient Albumin Price, 2018-2029
7 Sights by Application
7.1 Pharmaceutical Excipient Albumin Segment by Application
7.1.1 Cell Culture Media
7.1.2 Medical Supplements
7.2 By Application, Global Pharmaceutical Excipient Albumin Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Pharmaceutical Excipient Albumin Revenue, 2018-2029
7.4 By Application, Global Pharmaceutical Excipient Albumin Sales Volume, 2018-2029
7.5 By Application, Global Pharmaceutical Excipient Albumin Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Pharmaceutical Excipient Albumin Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Pharmaceutical Excipient Albumin Revenue, 2018-2029
8.3 By Region, Global Pharmaceutical Excipient Albumin Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Pharmaceutical Excipient Albumin Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Pharmaceutical Excipient Albumin Market Size Market Share
8.5 Europe
8.5.1 Europe Pharmaceutical Excipient Albumin Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Pharmaceutical Excipient Albumin Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Pharmaceutical Excipient Albumin Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Pharmaceutical Excipient Albumin Market Size Market Share
8.7 South America
8.7.1 South America Pharmaceutical Excipient Albumin Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Pharmaceutical Excipient Albumin Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Pharmaceutical Excipient Albumin Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Pharmaceutical Excipient Albumin Revenue, 2018-2029
9.3 By Country, Global Pharmaceutical Excipient Albumin Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.4.2 By Company, U.S. Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.5.2 By Company, Europe Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022
9.5.3 By Type, Europe Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.6.2 By Company, China Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022
9.6.3 By Type, China Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.7.2 By Company, Japan Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022
9.7.3 By Type, Japan Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.8.2 By Company, South Korea Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.10.2 By Company, India Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022
9.10.3 By Type, India Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Pharmaceutical Excipient Albumin Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 CSL
10.1.1 CSL Company Information, Head Office, Market Area and Industry Position
10.1.2 CSL Pharmaceutical Excipient Albumin Models, Specifications and Application
10.1.3 CSL Pharmaceutical Excipient Albumin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 CSL Company Profile and Main Business
10.1.5 CSL Recent Developments
10.2 Grifols
10.2.1 Grifols Company Information, Head Office, Market Area and Industry Position
10.2.2 Grifols Pharmaceutical Excipient Albumin Models, Specifications and Application
10.2.3 Grifols Pharmaceutical Excipient Albumin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Grifols Company Profile and Main Business
10.2.5 Grifols Recent Developments
10.3 Takeda
10.3.1 Takeda Company Information, Head Office, Market Area and Industry Position
10.3.2 Takeda Pharmaceutical Excipient Albumin Models, Specifications and Application
10.3.3 Takeda Pharmaceutical Excipient Albumin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Takeda Company Profile and Main Business
10.3.5 Takeda Recent Developments
10.4 Octapharma
10.4.1 Octapharma Company Information, Head Office, Market Area and Industry Position
10.4.2 Octapharma Pharmaceutical Excipient Albumin Models, Specifications and Application
10.4.3 Octapharma Pharmaceutical Excipient Albumin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Octapharma Company Profile and Main Business
10.4.5 Octapharma Recent Developments
10.5 Hualan Bio
10.5.1 Hualan Bio Company Information, Head Office, Market Area and Industry Position
10.5.2 Hualan Bio Pharmaceutical Excipient Albumin Models, Specifications and Application
10.5.3 Hualan Bio Pharmaceutical Excipient Albumin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Hualan Bio Company Profile and Main Business
10.5.5 Hualan Bio Recent Developments
10.6 CBPO
10.6.1 CBPO Company Information, Head Office, Market Area and Industry Position
10.6.2 CBPO Pharmaceutical Excipient Albumin Models, Specifications and Application
10.6.3 CBPO Pharmaceutical Excipient Albumin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 CBPO Company Profile and Main Business
10.6.5 CBPO Recent Developments
10.7 Shanghai RAAS
10.7.1 Shanghai RAAS Company Information, Head Office, Market Area and Industry Position
10.7.2 Shanghai RAAS Pharmaceutical Excipient Albumin Models, Specifications and Application
10.7.3 Shanghai RAAS Pharmaceutical Excipient Albumin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Shanghai RAAS Company Profile and Main Business
10.7.5 Shanghai RAAS Recent Developments
10.8 Kedrion
10.8.1 Kedrion Company Information, Head Office, Market Area and Industry Position
10.8.2 Kedrion Pharmaceutical Excipient Albumin Models, Specifications and Application
10.8.3 Kedrion Pharmaceutical Excipient Albumin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Kedrion Company Profile and Main Business
10.8.5 Kedrion Recent Developments
10.9 LFB Group
10.9.1 LFB Group Company Information, Head Office, Market Area and Industry Position
10.9.2 LFB Group Pharmaceutical Excipient Albumin Models, Specifications and Application
10.9.3 LFB Group Pharmaceutical Excipient Albumin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 LFB Group Company Profile and Main Business
10.9.5 LFB Group Recent Developments
10.10 Albumedix
10.10.1 Albumedix Company Information, Head Office, Market Area and Industry Position
10.10.2 Albumedix Pharmaceutical Excipient Albumin Models, Specifications and Application
10.10.3 Albumedix Pharmaceutical Excipient Albumin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Albumedix Company Profile and Main Business
10.10.5 Albumedix Recent Developments
10.11 Biotest
10.11.1 Biotest Company Information, Head Office, Market Area and Industry Position
10.11.2 Biotest Pharmaceutical Excipient Albumin Models, Specifications and Application
10.11.3 Biotest Pharmaceutical Excipient Albumin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Biotest Company Profile and Main Business
10.11.5 Biotest Recent Developments
10.12 Merck
10.12.1 Merck Company Information, Head Office, Market Area and Industry Position
10.12.2 Merck Pharmaceutical Excipient Albumin Models, Specifications and Application
10.12.3 Merck Pharmaceutical Excipient Albumin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Merck Company Profile and Main Business
10.12.5 Merck Recent Developments
10.13 Ventria (InVitria)
10.13.1 Ventria (InVitria) Company Information, Head Office, Market Area and Industry Position
10.13.2 Ventria (InVitria) Pharmaceutical Excipient Albumin Models, Specifications and Application
10.13.3 Ventria (InVitria) Pharmaceutical Excipient Albumin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Ventria (InVitria) Company Profile and Main Business
10.13.5 Ventria (InVitria) Recent Developments
10.14 HiMedia
10.14.1 HiMedia Company Information, Head Office, Market Area and Industry Position
10.14.2 HiMedia Pharmaceutical Excipient Albumin Models, Specifications and Application
10.14.3 HiMedia Pharmaceutical Excipient Albumin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 HiMedia Company Profile and Main Business
10.14.5 HiMedia Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Pharmaceutical Excipient Albumin Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Pharmaceutical Excipient Albumin Market Restraints
Table 3. Pharmaceutical Excipient Albumin Market Trends
Table 4. Pharmaceutical Excipient Albumin Industry Policy
Table 5. Global Pharmaceutical Excipient Albumin Revenue by Company, 2018-2023, US$ million
Table 6. Global Pharmaceutical Excipient Albumin Revenue Market Share by Company, 2018-2023
Table 7. Global Pharmaceutical Excipient Albumin Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Pharmaceutical Excipient Albumin Sales Volume Market Share by Company, 2018-2023
Table 9. Global Pharmaceutical Excipient Albumin Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Pharmaceutical Excipient Albumin Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Pharmaceutical Excipient Albumin Mergers & Acquisitions, Expansion Plans
Table 12. Global Pharmaceutical Excipient Albumin Manufacturers Product Type
Table 13. China Pharmaceutical Excipient Albumin Revenue by Company, 2018-2023, US$ million
Table 14. China Pharmaceutical Excipient Albumin Revenue Market Share by Company, 2018-2023
Table 15. China Pharmaceutical Excipient Albumin Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Pharmaceutical Excipient Albumin Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Pharmaceutical Excipient Albumin Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Pharmaceutical Excipient Albumin Import & Export Trends
Table 19. Main Sources of China Pharmaceutical Excipient Albumin Import
Table 20. Export Destination of China Pharmaceutical Excipient Albumin
Table 21. Global Headquarters and Manufacturing Base of Pharmaceutical Excipient Albumin Manufacturers
Table 22. Global Major Manufacturers, Pharmaceutical Excipient Albumin Capacity Expansion and Future Plans
Table 23. Global Pharmaceutical Excipient Albumin Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Pharmaceutical Excipient Albumin Production by Region, 2018-2023, (K Units)
Table 25. Global Pharmaceutical Excipient Albumin Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Pharmaceutical Excipient Albumin Upstream (Raw Materials)
Table 27. Global Pharmaceutical Excipient Albumin Typical Customers
Table 28. Pharmaceutical Excipient Albumin Typical Distributors
Table 29. By Type, Global Pharmaceutical Excipient Albumin Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Pharmaceutical Excipient Albumin Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Pharmaceutical Excipient Albumin Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Pharmaceutical Excipient Albumin Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Pharmaceutical Excipient Albumin Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Pharmaceutical Excipient Albumin Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Pharmaceutical Excipient Albumin Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Pharmaceutical Excipient Albumin Revenue Market Share, 2018-2029
Table 37. By Country, Global Pharmaceutical Excipient Albumin Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Pharmaceutical Excipient Albumin Sales Volume Market Share, 2018-2029
Table 39. CSL Company Information, Head Office, Market Area and Industry Position
Table 40. CSL Pharmaceutical Excipient Albumin Models, Specifications and Application
Table 41. CSL Pharmaceutical Excipient Albumin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. CSL Company Profile and Main Business
Table 43. CSL Recent Developments
Table 44. Grifols Company Information, Head Office, Market Area and Industry Position
Table 45. Grifols Pharmaceutical Excipient Albumin Models, Specifications and Application
Table 46. Grifols Pharmaceutical Excipient Albumin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Grifols Company Profile and Main Business
Table 48. Grifols Recent Developments
Table 49. Takeda Company Information, Head Office, Market Area and Industry Position
Table 50. Takeda Pharmaceutical Excipient Albumin Models, Specifications and Application
Table 51. Takeda Pharmaceutical Excipient Albumin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Takeda Company Profile and Main Business
Table 53. Takeda Recent Developments
Table 54. Octapharma Company Information, Head Office, Market Area and Industry Position
Table 55. Octapharma Pharmaceutical Excipient Albumin Models, Specifications and Application
Table 56. Octapharma Pharmaceutical Excipient Albumin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Octapharma Company Profile and Main Business
Table 58. Octapharma Recent Developments
Table 59. Hualan Bio Company Information, Head Office, Market Area and Industry Position
Table 60. Hualan Bio Pharmaceutical Excipient Albumin Models, Specifications and Application
Table 61. Hualan Bio Pharmaceutical Excipient Albumin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Hualan Bio Company Profile and Main Business
Table 63. Hualan Bio Recent Developments
Table 64. CBPO Company Information, Head Office, Market Area and Industry Position
Table 65. CBPO Pharmaceutical Excipient Albumin Models, Specifications and Application
Table 66. CBPO Pharmaceutical Excipient Albumin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. CBPO Company Profile and Main Business
Table 68. CBPO Recent Developments
Table 69. Shanghai RAAS Company Information, Head Office, Market Area and Industry Position
Table 70. Shanghai RAAS Pharmaceutical Excipient Albumin Models, Specifications and Application
Table 71. Shanghai RAAS Pharmaceutical Excipient Albumin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Shanghai RAAS Company Profile and Main Business
Table 73. Shanghai RAAS Recent Developments
Table 74. Kedrion Company Information, Head Office, Market Area and Industry Position
Table 75. Kedrion Pharmaceutical Excipient Albumin Models, Specifications and Application
Table 76. Kedrion Pharmaceutical Excipient Albumin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Kedrion Company Profile and Main Business
Table 78. Kedrion Recent Developments
Table 79. LFB Group Company Information, Head Office, Market Area and Industry Position
Table 80. LFB Group Pharmaceutical Excipient Albumin Models, Specifications and Application
Table 81. LFB Group Pharmaceutical Excipient Albumin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. LFB Group Company Profile and Main Business
Table 83. LFB Group Recent Developments
Table 84. Albumedix Company Information, Head Office, Market Area and Industry Position
Table 85. Albumedix Pharmaceutical Excipient Albumin Models, Specifications and Application
Table 86. Albumedix Pharmaceutical Excipient Albumin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Albumedix Company Profile and Main Business
Table 88. Albumedix Recent Developments
Table 89. Biotest Company Information, Head Office, Market Area and Industry Position
Table 90. Biotest Pharmaceutical Excipient Albumin Models, Specifications and Application
Table 91. Biotest Pharmaceutical Excipient Albumin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Biotest Company Profile and Main Business
Table 93. Biotest Recent Developments
Table 94. Merck Company Information, Head Office, Market Area and Industry Position
Table 95. Merck Pharmaceutical Excipient Albumin Models, Specifications and Application
Table 96. Merck Pharmaceutical Excipient Albumin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Merck Company Profile and Main Business
Table 98. Merck Recent Developments
Table 99. Ventria (InVitria) Company Information, Head Office, Market Area and Industry Position
Table 100. Ventria (InVitria) Pharmaceutical Excipient Albumin Models, Specifications and Application
Table 101. Ventria (InVitria) Pharmaceutical Excipient Albumin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Ventria (InVitria) Company Profile and Main Business
Table 103. Ventria (InVitria) Recent Developments
Table 104. HiMedia Company Information, Head Office, Market Area and Industry Position
Table 105. HiMedia Pharmaceutical Excipient Albumin Models, Specifications and Application
Table 106. HiMedia Pharmaceutical Excipient Albumin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. HiMedia Company Profile and Main Business
Table 108. HiMedia Recent Developments
List of Figure
Figure 1. Pharmaceutical Excipient Albumin Picture
Figure 2. By Revenue, Global Pharmaceutical Excipient Albumin Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Pharmaceutical Excipient Albumin Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Pharmaceutical Excipient Albumin Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Pharmaceutical Excipient Albumin Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Pharmaceutical Excipient Albumin Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Pharmaceutical Excipient Albumin Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Pharmaceutical Excipient Albumin Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Pharmaceutical Excipient Albumin Share of Global Market, 2018-2029
Figure 10. Global Pharmaceutical Excipient Albumin Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Pharmaceutical Excipient Albumin Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Pharmaceutical Excipient Albumin Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Pharmaceutical Excipient Albumin Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Pharmaceutical Excipient Albumin Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Pharmaceutical Excipient Albumin Domestic VS Export, 2022
Figure 16. Global Pharmaceutical Excipient Albumin Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Pharmaceutical Excipient Albumin Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Pharmaceutical Excipient Albumin Production Market Share & Forecast by Region, 2018-2029
Figure 19. Pharmaceutical Excipient Albumin Industry Chain
Figure 20. Pharmaceutical Excipient Albumin Procurement Model
Figure 21. Pharmaceutical Excipient Albumin Sales Model
Figure 22. Pharmaceutical Excipient Albumin Sales Channels, Direct Sales and Distribution
Figure 23. Human Serum Albumin
Figure 24. Recombinant Albumin
Figure 25. By Type, Global Pharmaceutical Excipient Albumin Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Pharmaceutical Excipient Albumin Revenue Market Share, 2018-2029
Figure 27. By Type, Global Pharmaceutical Excipient Albumin Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global Pharmaceutical Excipient Albumin Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Pharmaceutical Excipient Albumin Price, 2018-2029, (US$/Unit)
Figure 30. Cell Culture Media
Figure 31. Medical Supplements
Figure 32. By Application, Global Pharmaceutical Excipient Albumin Revenue, 2018-2029, US$ Million
Figure 33. By Application, Global Pharmaceutical Excipient Albumin Revenue Market Share, 2018-2029
Figure 34. By Application, Global Pharmaceutical Excipient Albumin Sales Volume, 2018-2029, (K Units)
Figure 35. By Application, Global Pharmaceutical Excipient Albumin Sales Volume Market Share, 2018-2029
Figure 36. By Application, Global Pharmaceutical Excipient Albumin Price, 2018-2029, (US$/Unit)
Figure 37. By Region, Global Pharmaceutical Excipient Albumin Revenue Market Share, 2018-2029
Figure 38. By Region, Global Pharmaceutical Excipient Albumin Sales Volume Market Share, 2018-2029
Figure 39. North America Pharmaceutical Excipient Albumin Revenue & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America Pharmaceutical Excipient Albumin Revenue Market Share, 2022
Figure 41. Europe Pharmaceutical Excipient Albumin Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe Pharmaceutical Excipient Albumin Revenue Market Share, 2022
Figure 43. Asia Pacific Pharmaceutical Excipient Albumin Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific Pharmaceutical Excipient Albumin Revenue Market Share, 2022
Figure 45. South America Pharmaceutical Excipient Albumin Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America Pharmaceutical Excipient Albumin Revenue Market Share, 2022
Figure 47. Middle East & Africa Pharmaceutical Excipient Albumin Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. Pharmaceutical Excipient Albumin Sales Volume, 2018-2029, (K Units)
Figure 49. By Company, U.S. Pharmaceutical Excipient Albumin Market Share, 2022
Figure 50. By Type, U.S. Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022 VS 2029
Figure 51. By Application, U.S. Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022 VS 2029
Figure 52. Europe Pharmaceutical Excipient Albumin Sales Volume, 2018-2029, (K Units)
Figure 53. By Company, Europe Pharmaceutical Excipient Albumin Market Share, 2022
Figure 54. By Type, Europe Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, Europe Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022 VS 2029
Figure 56. China Pharmaceutical Excipient Albumin Sales Volume, 2018-2029, (K Units)
Figure 57. By Company, China Pharmaceutical Excipient Albumin Market Share, 2022
Figure 58. By Type, China Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, China Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022 VS 2029
Figure 60. Japan Pharmaceutical Excipient Albumin Sales Volume, 2018-2029, (K Units)
Figure 61. By Company, Japan Pharmaceutical Excipient Albumin Market Share, 2022
Figure 62. By Type, Japan Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, Japan Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022 VS 2029
Figure 64. South Korea Pharmaceutical Excipient Albumin Sales Volume, 2018-2029, (K Units)
Figure 65. By Company, South Korea Pharmaceutical Excipient Albumin Market Share, 2022
Figure 66. By Type, South Korea Pharmaceutical Excipient Albumin Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, South Korea Pharmaceutical Excipient Albumi
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|